Cyltezo®, first and only FDA-approved Interchangeable biosimilar to Humira®, now commercially available in the U.S. ...Middle East

Cyltezo® (adalimumab-adbm) expands treatment options for patients across multiple chronic inflammatory diseases Cyltezo is the only adalimumab biosimilar with Phase III comparative clinical studies in rheumatoid arthritis, plaque psoriasis and Crohn's disease RIDGEFIELD, Conn., July 1,...

Hence then, the article about cyltezo first and only fda approved interchangeable biosimilar to humira now commercially available in the u s was published today ( Saturday 01/07/2023 - 03:37 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Cyltezo®, first and only FDA-approved Interchangeable biosimilar to Humira®, now commercially available in the U.S. )

Also on site :

• One person in critical condition following two-vehicle collision on SR-126 at Boosey Road
• Kentucky congressman announces death of longtime staffer, campaign manager
• Camarillo man arrested after stolen camera reactivated and installed on the exterior of a home